William J. Febbo

William J. Febbo, listed as chief executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in OptimizeRx Corp, Modular Medical, Inc. and Augmedix, Inc. Between 9 June 2016 and 25 June 2026, the trades on record add up to 62 filings.

In open-market terms, that means 12 purchases worth €511k on one side and 13 sales worth €10.3M on the other. Sales outweigh purchases by €9.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 21 share grants and 14 option exercises.

The median purchase comes to €14k. 9 out of 12 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 26 June 2026: a share grant, in Myomo, Inc. The latest purchase dates back some time: it was published 677 days ago, on 16 December 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.